Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2

BACKGROUND: Ombitasvir, paritaprevir with ritonavir, and dasabuvir (OBV/PTV/r ± DSV) ±ribavirin (RBV) are approved to treat hepatitis C virus (HCV) genotype 1 and 4 infection. Here, we investigate the safety and efficacy of OBV/PTV/r + DSV ±RBV for HCV genotype 1, and OBV/PTV/r + RBV for HCV genotyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Rockstroh, Jürgen K, Orkin, Chloe, Viani, Rolando M, Wyles, David, Luetkemeyer, Anne F, Lazzarin, Adriano, Soto-Malave, Ruth, Nelson, Mark R, Bhagani, Sanjay R, Klinker, Hartwig H F, Rizzardini, Giuliano, Girard, Pierre-Marie, Tural, Cristina, Shulman, Nancy S, Mobashery, Niloufar, Hu, Yiran B, Fredrick, Linda M, Pilot-Matias, Tami, Trinh, Roger, Gane, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597897/
https://www.ncbi.nlm.nih.gov/pubmed/28948180
http://dx.doi.org/10.1093/ofid/ofx154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597897/
https://www.ncbi.nlm.nih.gov/pubmed/28948180
http://dx.doi.org/10.1093/ofid/ofx154

Ejemplares similares